Page 3 - Dr Reddys Laboratories Ltd News
Stocks to Watch today, Dec 15: Swiggy, BEL, Tata Elxsi, Aurobindo Pharma
Stocks to watch today, December 15, 2025: From Tata Elxsi to Aurobindo Pharma, here is a list of stocks to keep in focus
 "Stocks to Watch today, Dec 15: Swiggy, BEL, Tata Elxsi, Aurobindo Pharma")
Larger HC Bench clears way for export of semaglutide generics by Dr Reddy's
Novo Nordisk's appeal was listed for hearing on Friday before a bench of Justice C Hari Shankar and Justice Om Prakash Shukla
 "Larger HC Bench clears way for export of semaglutide generics by Dr Reddy's")
Dr Reddy's signs licensing pact with Immutep to develop, market cancer drug
According to the agreement, Immutep will receive from Dr Reddy's an upfront payment of $20 million (around AUD 30.2 million)
 "Dr Reddy's signs licensing pact with Immutep to develop, market cancer drug")
Dr Reddy's signs licensing pact to sell Australian Immutep's cancer drug
Over the last few years, Dr Reddy's has diversified its portfolio beyond generics to include cancer therapies as it battles pricing pressures in North America, its largest market
Rupee at record low, MPC caution drag Nifty; check strategy, stock picks
Sentiment was dampened by a weakening rupee, which hit a record low of 90.13 against the dollar, heightening concerns around import costs and triggering FII outflows
 "Rupee at record low, MPC caution drag Nifty; check strategy, stock picks")
Nifty50 to hit 29,300 by end-2026? Nomura lists top 20 stock picks
Nomura expects Indian markets to trade in the range of 20-22x one-year forward earnings, assuming risk premia remain low.
 "Nifty50 to hit 29,300 by end-2026? Nomura lists top 20 stock picks")